TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

BELCHER PHARMS

OncologyInfectious DiseaseDermatology
Generics

BELCHER PHARMS is a generic drug manufacturer focused on Oncology, Infectious Disease, Dermatology.

1971
Since
2
Drugs
-
Trials
12
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PENICILLIN V POTASSIUM 2025-10-31
Labeling
PENICILLIN V POTASSIUM 2025-10-31
Labeling
PENICILLIN V POTASSIUM 2025-10-31
Labeling
AMPICILLIN TRIHYDRATE 2025-09-02
Labeling
AMPICILLIN TRIHYDRATE 2024-05-01
Labeling
AMPICILLIN TRIHYDRATE 2024-05-01
Labeling
AMPICILLIN TRIHYDRATE 2024-05-01
Labeling
AMPICILLIN TRIHYDRATE 2024-05-01
Labeling
AMPICILLIN TRIHYDRATE 2024-05-01
Labeling
AMPICILLIN TRIHYDRATE 2024-05-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 52%
0 drugs Phase 3: 3 Phase 1: 2
Infectious Disease 30%
0 drugs Phase 3: 1 Phase 2: 2
Dermatology 19%
0 drugs Phase 3: 1 Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Oncology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology